GRANT NUMBER: ___Michae] Karin
‘BIOGRAPHICAL SKETCH

Give the following information tor ail new key personnel, coms
Copy this page for each gerson

@ ii — erm
Anning Lin Postgraduate Research Pharmacologist

 

5 ein reais ihn prlosslons aducalion, soci a mrsing, and Iced postgocio

YEAR
INSTITUTION AND LOCATION becnce | contennen

Xuzhou Medical Coll (izhou, China| M.D. 1982 "| —-Wedieine

Nanking University, Nanking, Chine M8. 1985 Biochemistry
University of Alabama at Birmingham Ph.D. | 1990 Pharmacology
University of California, San Diego Postdoc | 1991-Pres.| Pharmacology

FIELD OF STUDY

RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position ist, in chronological order, previous employment, ex
perience, and honois. Key personnel include the principal investigator and ay other individual who participate in the selenite development
‘0F execulion of the project. Key personnel typically will include all individuals with doctoral or other prolessionst degrees but in some pro
Jects will Include individuals al the masters or baccalaureate level provided hey contibuto a substantive way to the Sclenlilic development
cutlon of the project. Include present membership on any Federal Govesnment public advisory commiliee, List, in chronologteal order,
{he tiles, all authors, and complete relerences to all publiclions during the past iluee years and to representative eater publications per
this application, DO NOT EXCEED TWO PAGES,

1982-1985 Teaching Assistant, Department of Biochemistry, Nanking University,
China

1986-1990 Graduate Student, Department of Pharmacology, University of Alabama at
Birmingham

1991-Pres. Postgraduate Researcher, Department of Pharmacology, University of
California, San Diego

SOCIETY MEMBERSHIPS
Chinese Society for Biochemistry
‘PUBLICATIONS AND ABSTRACTS

Lin, A., Chao, S-H, Cheng, L.T. (1986) Changes of calmodulin level and phospho-
Glesterase activity in development chick brain. Chinese Biochem. J. 2, 75-82.

Lin, A. and Wallace, R.W. (1989) Partial purification and characterization of inositol
1,4,5-trisphosphate 3-kinase from human platelets. PASEB J. 3, A1287.

Lin, A., Barnes, $. and Wallace, R.W. (1990) Phosphorylation by protein kinase ¢
inactivates an inositol 1,4,5-trisphosphate 3-kinase purified from human platelets.
Biochem. Biophys. Res. Commun. 170, 1371-1376.

Lin, A., Wallace, R.W. and Barnes, S. (1990) Identification of a 36 kDa polypeptide as
inositol 1,4,5-trisphosphate 3-kinase in human platelets. FASEB J. 4, A2081.

Lin, A., Barnes, S. and Wallace, R.W. Purification and properties of inositol 1,4,5-
trisphosphate 3-kinase from human platelets (Submitted).

Lin, A., Frost, J., Deng, T., Al-Alawi, N., Smeal, T., Kikkawa, U., Hunter, T.,
Brenner, D. and Karin, M. Casein kinase II 1s a negative regulator of cJun DNA
binding and AP-1 activity. Coll, submitted, 1992.

Alberts, A.S., Deng, T., Lin, A., Meinkoth, J.L., Schonthal, A., Humby, M.C., Karin, M.
and Feramisco, J.R. Protein phosphatase 2A differentially regulates promoters
containing SRE or TRE elements. J, Gell. Biol., submitted, 1992,

 

iS 39872590 ew 8) Wom Page 4) Pose

 

50684275
